Get out of cash NOW
Millionaire Wall Street Legend Urges Americans To Get Out Of CASH before April 27th.
Details here.
pixel

CLBS Insider Trading (Caladrius Biosciences)

Insider Ownership Percentage: 10.30%
Insider Buying (Last 12 Months): $99,945.00
Insider Selling (Last 12 Months): $0.00

Caladrius Biosciences Insider Trading History Chart

Caladrius Biosciences Share Price & Price History

$1.76
▲ +0.05 (2.92%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Man Who Predicted March 2020 Crash Says 2021 Is The Time
If you've got money invested in the stock market, but are confused as to what to do next...This is the can't-miss interview of 2021...
Learn more here!

Caladrius Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/9/2020Michael H. DavidsonDirectorBuy55,525$1.80$99,945.00  
See Full Table

SEC Filings (Institutional Ownership Changes) for Caladrius Biosciences (NASDAQ:CLBS)

8.99% of Caladrius Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Caladrius Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
3/8/2021Dimensional Fund Advisors LP20,548$29K0.0%-37.1%0.062%
2/25/2021Dimensional Fund Advisors LP20,548$29K0.0%-37.1%0.062%
2/24/2021Virtu Financial LLC52,599$75K0.0%N/A0.160%
2/16/2021Squarepoint Ops LLC20,637$30K0.0%N/A0.063%
2/10/2021Renaissance Technologies LLC1,045,855$1.50M0.0%+12.8%3.173%
11/9/2020Acadian Asset Management LLC156,668$0.28M0.0%+119.0%0.811%
5/15/2020Summit Trail Advisors LLC17,730$32K0.0%N/A0.138%
2/13/2020Renaissance Technologies LLC411,401$1.03M0.0%+5.0%3.956%
8/14/2019Vanguard Group Inc.207,973$0.47M0.0%+7.6%1.999%
8/13/2019BlackRock Inc.29,107$66K0.0%-42.6%0.280%
8/12/2019Renaissance Technologies LLC380,336$0.87M0.0%+20.6%3.663%
5/9/2019Wesbanco Bank Inc.10,000$36K0.0%N/A0.096%
4/1/2019Deutsche Bank AG51,011$0.18M0.0%-11.0%0.513%
12/13/2018Vanguard Group Inc202,568$1.20M0.0%+2.9%2.059%
11/13/2018Renaissance Technologies LLC280,864$1.66M0.0%+42.9%2.854%
8/13/2018Renaissance Technologies LLC196,563$1.27M0.0%+33.7%2.022%
5/11/2018Dimensional Fund Advisors LP33,765$0.20M0.0%N/A0.353%
5/10/2018JPMorgan Chase & Co.18,771$0.11M0.0%N/A0.196%
2/15/2018Macquarie Group Ltd.29,890$0.11M0.0%+321.0%0.316%
5/12/2017KCG Holdings Inc.36,291$0.18M0.0%+74.6%0.000%
5/12/2017Renaissance Technologies LLC97,552$0.49M0.0%+34.3%0.000%
2/13/2017Renaissance Technologies LLC72,652$0.21M0.0%+149.2%0.000%
11/15/2016Knoll Capital Management LP55,781$0.27M0.5%N/A0.000%
5/16/2016Jacobs Levy Equity Management Inc.165,691$0.12M0.0%N/A0.281%
5/13/2016Geode Capital Management LLC293,305$0.22M0.0%0.0%0.530%
5/10/2016BlackRock Institutional Trust Company N.A.246,414$0.19M0.0%No Change0.445%
Data available starting January 2016

See Full Table
Caladrius Biosciences logo
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, develops cellular therapeutic product candidates to address diseases and conditions caused by ischemia. Its product candidates include developmental treatments for cardiovascular diseases, such as CLBS12 for the treatment of critical limb ischemia; CLBS16, which is in Phase II clinical trial for the treatment of coronary microvascular dysfunction; CLBS14, a regenerative medicine advanced therapy for treating no-option refractory disabling angina. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was founded in 1980 and is headquartered in Basking Ridge, New Jersey.
Read More

Today's Range

Now: $1.76
$1.71
$1.79

50 Day Range

MA: $1.97
$1.71
$2.29

52 Week Range

Now: $1.76
$1.25
$4.89

Volume

983,838 shs

Average Volume

6,117,712 shs

Market Capitalization

$104.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.55

Who are the company insiders with the largest holdings of Caladrius Biosciences?

Caladrius Biosciences' top insider investors include:
  1. Michael H Davidson (Director)
Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video)
"Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project…

What happens next will shock you…"
Click here to see what happened.